Loading
Life sciences · Observational Study
ClinicalTrials.gov · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07894705). This is a study registration, not published results. Lead sponsor: Ohio State University. Recruitment status: NOT_YET_RECRUITING. Study type: OBSERVATIONAL. Enrollment: 68 participants (ESTIMATED). Conditions: Hypertensive Disorder of Pregnancy, Preeclampsia. Interventions: OTHER: Treating BP acutely with intravenous or rapid acting oral medications. Primary outcome measures: Mean latency from diagnosis of hypertensive disorders of pregnancy (HDP) to delivery (continuous, mean with standard deviation) , from randomization to delivery. Brief summary: The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients with hypertensive disorders of pregnancy (HDP) with severe features \< 34 weeks gestational age (GA), undergoing expectant management between tight and permissive blood pressure (BP) groups.